Ticker Details
Replimune Group, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$713.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.21%
Avg Daily Range (30 D):	$0.26 | 3.43%
Avg Daily Range (90 D):	$0.25 | 2.96%

Institutional Daily Volume
Avg Daily Volume:	.8M
Avg Daily Volume (30 D):	1.21M
Avg Daily Volume (90 D):	2.76M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	2,302
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.38M
Avg Institutional Trade (90 D):	$1.51M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.78M
Avg Closing Trade (30 D):	$1.23M
Avg Closing Trade (90 D):	$1.76M
Avg Closing Volume:	128.69K

News

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 7, 2025 @ 9:45 PM Replimune Presents Late-Breaking Abstract and Addi... Source: Replimune Group, Inc.

Oct 20, 2025 @ 8:10 PM Why Replimune Stock Was Soaring Today Source: Eric Volkman

Oct 20, 2025 @ 11:00 AM Replimune Announces FDA Acceptance of BLA Resubmis... Source: Sushil Patel, Ph.D., Ceo Of Replimune

Oct 19, 2025 @ 12:00 PM Replimune Highlights Acral Melanoma Data for RP1 p... Source: Replimune Group, Inc.

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-3.44	$-.77	$-.9
Diluted EPS	$-3.44	$-.77	$-.9
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-314.85M	$-70.93M	$-83.1M
Operating Income / Loss	$-325.91M	$-71.87M	$-84.29M
Cost of Revenue
Net Cash Flow	$-49.29M	$20.65M	$4.92M
PE Ratio

Splits
Dec 01, 2010	15:1